The State Food and Drug Administration (SFDA) issued the No.74 Drug Administrative Protection Announcement on November 18, 2005, declaring the ending of drug administrative protection for Fujisawa Pharmceutical's tacrolimus.

The State Food and Drug Administration (SFDA) issued the No.75 Drug Administrative Protection Announcement on November 18, 2005, declaring the ending of drug administrative protection for Fujisawa Pharmceutical's Prograf (tacrolimus) capsule.

The State Food and Drug Administration (SFDA) issued the No.76 Drug Administrative Protection Announcement on November 21, 2005, declaring the ending of drug administrative protection for Zeneca 's Casodex (bicalutamide) tablet, UK.

The State Food and Drug Administration (SFDA) issued the No.77 Drug Administrative Protection Announcement on November 21,2005, declaring the ending of drug administrative protection for Zeneca's Accolate (zafirlukast), US